Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study (Q34960850)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

multicenter clinical trial

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

M R Smith

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

S B Malkowicz

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

F Chu

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

J Forrest

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

D Price

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

P Sieber

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

K G Barnette

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

D Rodriguez

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

M S Steiner

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

14 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

179

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

152-155

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Toremifene: an evaluation of its safety profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Vitamin D receptor genotypes are related to bone size and bone density in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Changes in body composition during androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

The incidence of vertebral fractures in men and women: the Rotterdam Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal fractures negatively correlate with overall survival in men with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective estrogen receptor modulators to prevent treatment-related osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JURO.2007.08.137

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34960850&oldid=1980119566"